FdaApplication
BLA 761434
Identifiers
- fda_app_no: BLA761434
Properties
| Property | Value |
|---|---|
| applicant_name | Otsuka Pharmaceutical Company, Ltd. |
| application_type | BLA |
| approval_date | 2025-11-25 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VOYXACT | SIBEPRENLIMAB-SZSI | 400MG/2ML (200MG/ML) | Injection |
1 product